Key documents

• Statement on air freight of critical medicines & supplies
• Best practice guidance on how to protect workers in relation to Covid-19
• Critical to keep the supply chain of essential medicines manufacturing operating at full capacity
• EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms
• Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe
• Coordination with industry on potential impact of Covid-19 on medicines manufacturing and supplies in Europe
• Medicines for Europe statement on COVID-19 (‘coronavirus’)
• Medicines for Europe urgent requests to Interior & Transport ministries regarding medicines production and supply
• Medicines for Europe update regarding medicines production and supply related to Covid-19

Useful links

• MOH JO: Coronavirus (COVID-19)
• EMA: Coronavirus disease (COVID-19)
• WHO: Coronavirus disease (COVID-19) outbreak
• CDC: Coronavirus (COVID-19)
• Worldmeters: COVID-19 CORONAVIRUS PANDEMIC